Australian (ASX) Stock Market Forum

PCK - PainChek Ltd

Jump to new
System

System

Joined
27 June 2010
Posts
4,147
Reactions
309
Merah Resources Limited (MEH) has acquired 100% of the Mt Adamson Project located 28kms west of Leinster, Western Australia and secured an option to earn an 80% interest in the Bounty and McAuley Projects located 5kms north of the Mt Adamson Project.

The company plans to actively explore the three project areas in the immediate term by targeted and cost effective work programmes with the objective of discovering mineralisation that has the potential to be defined as a JORC Code compliant mineral resource.

http://www.merahresources.com.au
 
Re: MEH - Merah Resources

For those that like to speculate on new drilling prospects.
http://www.asx.com.au/asxpdf/20120709/pdf/4279kb6dpfjwd6.pdf

MERAH TO COMMENCE DRILLING ON PRIORITY LAWLERS TARGETS
● A review of the geological and exploration data received as part of the
Bounty and McAuley farm-in arrangements has identified a number of drill ready targets.
● WA Department of Mines and Petroleum approval for the detailed programme of work has now been received.
● Drill programme to commence in July 2012.
● Initial 8 hole RC programme to test identified targets within the Agnew – Wiluna greenstone belt.

The Lawlers Project tenements are owned by Murchison Resources Limited. The Company has the exclusive right to earn an 80% interest in the mineral rights within the Lawlers Project area pursuant to an agreement between the Company and Murchison.

The programme is expected to be completed in early August 2012.

No buyers, no sellers at the moment.
 
Re: MNQ - Minquest Limited

On December 16th, 2014, Merah Resources Limited (MEH) changed its name and ASX code to Minquest Limited (MNQ).
 
On October 18th, 2016, Minquest Limited (MNQ) changed its name and ASX code to ePAT Technologies Limited (EPT).
 
♦ http://healthsciences.curtin.edu.au/faculty-news/pvc-message-may-2016/sop-app/

♦ Support from the CSIRO, Alzheimer's Australia AND the Dementia Society of America.

♦ Upcoming implementation studies with industry partners, including Bupa. (Bupa has revenue of £9.8 billion GBP)

♦ EPT has signed a binding MoU with Strenuus, a UK-based insurance counter-fraud group, with the intention of developing a scalable anti-fraud medical-legal assessment platform through the integration of ePATs capabilities within Strenuus behavioural assessment platform.

♦ If the development of the platform proves successful, this could potentially open up ePAT to the insurance counter-fraud market in the UK and globally.

♦ According to a report of the Association of British Insurers dated December 2013, whiplash claims cost the UK insurance industry L2 billion (A$3.9 billion) a year.

♦ First mover advantage http://www.smh.com.au/federal-polit...ng-under-turnbull-scheme-20161203-gt39s7.html

♦ The government, which is chipping in $70 million, hopes the fund will turn innovative start-ups into businesses that create jobs and boost exports. Projects include ePAT, real-time facial recognition technology that assesses pain in people who cannot communicate verbally.

♦ A report commissioned by Alzheimer's Australia, released yesterday, indicates that this year, dementia is estimated to cost Australia $14.67 billion

♦ https://www.fightdementia.org.au/The-economic-cost-of-dementia-in-Australia-2016-to-2056.pdf

♦ This is projected to be $36.85 billion a year by 2056. Costing Australia a massive $1.033 trillion over the next 40 years.

♦ Market cap ~$16 million, with cash in the bank of ~$3.5 million, and low cash burn. Development of the app is cost-effective, and highly scalable.

♦ The board are all medical professionals or established doctors - significant experience including Cochlear, Resmed and Roche.

♦ Full results of the implementation study will be presented at the 2017 Australian Pain Society 37th Annual Scientific Meeting in April, where ePAT will also be presenting as a company for the first time in front of an international audience.

♦ https://www.dcconferences.com.au/aps2017/

Disclosure: Holding
 
On January 22nd, 2018, ePAT Technologies Limited (EPT) changed its name and ASX code to PainChek Ltd (PCK).
 
PainChek Ltd down 14.29% to 6c today after announcing that FDA regulatory clearance of the company's PainChek™ medical device will not occur by the end of calendar year 2018 as previously advised.

The FDA have advised PCK that they will have to provide clinical performance data to support their pre-market submission under section 513(f)(2) of the Federal Food, Drug, and Cosmetic Act. This means that a US-based clinical trial may be required.

Delays and regulatory uncertainty are not a good combination and many are exiting PCK today and looking for better opportunities elsewhere.

big.chart-PCK.gif
 
The idea behind painchek is reasonable enough. But if a healthcare provider didn't know when a patient was in pain by looking at their facial expression and listening to their tone of voice, they shouldn't be in the job. The training video on the website is utterly ridiculous. Makes me absolutely furious this crap.

Patient: "arghhhhh awww ow"
Nurse: "hmm, I can see you're in pain"
Patient: "arghhhhhhh owwwwww"
Nurse: "hmmm, your hands are on your knee. I wonder what that means...DUH. Let me take a picture of your pained facial expression and let the ipad decide if I'm going to help you with that pain".

What sort of idiots do they take us for??

 
Last edited:
PainChek making some gains following the release of a detailed Company Presentation on 11 September. Since then its share price has risen from 5c to a high of 6.9c today, although it is currently trading at 6.6c.

big.chart-PCK.gif
 
After finding support at 3c, the PainChek share price has spiked again today after the release of their latest Quarterly Report and news that the Federal government will invest $5 million to facilitate the implementation of the PainChek app in Australian residential aged care centres.

The catalyst for today's share price increase must be the news of the $5 million grant from the Federal government as the Quarterly Report detailed quarterly revenue of just $32,000 and a quarterly loss of $686,000.

Still, the PCK share price is up 67.65% to 5.7c this morning. Not a bad recovery at all. However, I do think that in the absence of news about increasing revenues generally it will probably struggle a bit from here and after today's exuberance the PCK share price will probably retreat a little from today's highs. There looks to be some support around the 5c mark.

That being said, I could be completely wrong.

big.chart-PCK.gif
 
Oops, forgot to post here after picking for comp.

Chose this on the anticipation of news around the UK rollout after CE Mark being given for their facial recognition based pain detection app.

SP aside, this would be a good way for any aged care facility to generate some good publicity by providing it to their carers and tend to their dementia patients. Not only should it detect pain in those unable to communicate it otherwise, you could use teh app to tell whether pain relief medication is being effective.
 
If today's cap raise announcement turns out to be at a significant discount, that might be one explanation for the heavier downswing volume (7955).

Previous chart had wrong numbers displayed. Last trading day before the ann saw a 13% rise for only 2.3 million traded shares.

x.jpg
 
Price remains in the VC bar range. No concerns at this point. The details of the capital raising will be interesting.
On a lighter note. I was wondering if the PCK app is able to recognise and quantitate the pain level when used on traders and investors. This could be very helpful. If the app recognises severe pain when the trader/investor looks at their broker account, the app would close down all the losers until the facial pain level of the trader/investor subsides.
 
Painchek has had a remarkable year. I'm tipping it will continue its rise next month.
upload_2019-9-18_10-20-40.png
 
A big measured move up is complete and there's a fair bit of selling pressure the last few days. I think it might finish today near 30 and start a down leg.
 
March Tipping Comp pick

as with most stocks PCK SP is not looking to healthy. I could continue down ( more than likely ) but with roll the dice here and hope it finds support at $0.10

The directors report paints a nice picture but you would expect that, but if they can get some traction then and more agreements signed then up she goes.

upload_2020-3-1_10-15-43.png
 
Top